UniProt ID | SGPL1_HUMAN | |
---|---|---|
UniProt AC | O95470 | |
Protein Name | Sphingosine-1-phosphate lyase 1 {ECO:0000305} | |
Gene Name | SGPL1 {ECO:0000312|HGNC:HGNC:10817} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 568 | |
Subcellular Localization |
Endoplasmic reticulum membrane Single-pass type III membrane protein . |
|
Protein Description | Cleaves phosphorylated sphingoid bases (PSBs), such as sphingosine-1-phosphate, into fatty aldehydes and phosphoethanolamine. Elevates stress-induced ceramide production and apoptosis.. | |
Protein Sequence | MPSTDLLMLKAFEPYLEILEVYSTKAKNYVNGHCTKYEPWQLIAWSVVWTLLIVWGYEFVFQPESLWSRFKKKCFKLTRKMPIIGRKIQDKLNKTKDDISKNMSFLKVDKEYVKALPSQGLSSSAVLEKLKEYSSMDAFWQEGRASGTVYSGEEKLTELLVKAYGDFAWSNPLHPDIFPGLRKIEAEIVRIACSLFNGGPDSCGCVTSGGTESILMACKAYRDLAFEKGIKTPEIVAPQSAHAAFNKAASYFGMKIVRVPLTKMMEVDVRAMRRAISRNTAMLVCSTPQFPHGVIDPVPEVAKLAVKYKIPLHVDACLGGFLIVFMEKAGYPLEHPFDFRVKGVTSISADTHKYGYAPKGSSLVLYSDKKYRNYQFFVDTDWQGGIYASPTIAGSRPGGISAACWAALMHFGENGYVEATKQIIKTARFLKSELENIKGIFVFGNPQLSVIALGSRDFDIYRLSNLMTAKGWNLNQLQFPPSIHFCITLLHARKRVAIQFLKDIRESVTQIMKNPKAKTTGMGAIYGMAQTTVDRNMVAELSSVFLDSLYSTDTVTQGSQMNGSPKPH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MPSTDLLMLK -----CCCHHHHHHH | 33.00 | 21406692 | |
4 | Phosphorylation | ----MPSTDLLMLKA ----CCCHHHHHHHH | 25.46 | 20068231 | |
8 | Sulfoxidation | MPSTDLLMLKAFEPY CCCHHHHHHHHHHHH | 4.73 | 21406390 | |
25 | Ubiquitination | ILEVYSTKAKNYVNG HHHHHCCCCHHCCCC | 51.96 | 21906983 | |
30 | Ubiquitination | STKAKNYVNGHCTKY CCCCHHCCCCCCCCC | 10.93 | 23000965 | |
34 | Ubiquitination | KNYVNGHCTKYEPWQ HHCCCCCCCCCCHHH | 3.58 | 21890473 | |
49 | Ubiquitination | LIAWSVVWTLLIVWG HHHHHHHHHHHHHHC | 4.52 | 21890473 | |
51 | Ubiquitination | AWSVVWTLLIVWGYE HHHHHHHHHHHHCCH | 1.48 | 21890473 | |
75 | Ubiquitination | SRFKKKCFKLTRKMP HHHHHHHHHHHHHCC | 11.31 | 23000965 | |
80 | Ubiquitination | KCFKLTRKMPIIGRK HHHHHHHHCCCCCHH | 43.74 | - | |
91 | Ubiquitination | IGRKIQDKLNKTKDD CCHHHHHHHHCCHHH | 37.27 | - | |
91 | 2-Hydroxyisobutyrylation | IGRKIQDKLNKTKDD CCHHHHHHHHCCHHH | 37.27 | - | |
101 | Ubiquitination | KTKDDISKNMSFLKV CCHHHHHHCCCEEEC | 57.93 | 29967540 | |
104 | Phosphorylation | DDISKNMSFLKVDKE HHHHHCCCEEECCHH | 36.50 | 24719451 | |
107 | Ubiquitination | SKNMSFLKVDKEYVK HHCCCEEECCHHHHH | 46.51 | 33845483 | |
110 | Ubiquitination | MSFLKVDKEYVKALP CCEEECCHHHHHHCC | 54.66 | 23000965 | |
114 | Ubiquitination | KVDKEYVKALPSQGL ECCHHHHHHCCCCCC | 43.22 | 23000965 | |
118 | Phosphorylation | EYVKALPSQGLSSSA HHHHHCCCCCCCHHH | 37.42 | 30266825 | |
122 | Phosphorylation | ALPSQGLSSSAVLEK HCCCCCCCHHHHHHH | 29.13 | 30266825 | |
123 | Phosphorylation | LPSQGLSSSAVLEKL CCCCCCCHHHHHHHH | 27.62 | 30266825 | |
124 | Phosphorylation | PSQGLSSSAVLEKLK CCCCCCHHHHHHHHH | 21.01 | 30266825 | |
129 | Ubiquitination | SSSAVLEKLKEYSSM CHHHHHHHHHHHCCC | 61.78 | 23000965 | |
131 | Ubiquitination | SAVLEKLKEYSSMDA HHHHHHHHHHCCCHH | 66.72 | 23000965 | |
133 | Phosphorylation | VLEKLKEYSSMDAFW HHHHHHHHCCCHHHH | 12.40 | 30624053 | |
134 | Phosphorylation | LEKLKEYSSMDAFWQ HHHHHHHCCCHHHHH | 21.93 | 30624053 | |
135 | Phosphorylation | EKLKEYSSMDAFWQE HHHHHHCCCHHHHHC | 21.56 | 30624053 | |
148 | Ubiquitination | QEGRASGTVYSGEEK HCCCCCCCEECCHHH | 17.49 | 27667366 | |
151 | Ubiquitination | RASGTVYSGEEKLTE CCCCCEECCHHHHHH | 35.08 | 23503661 | |
155 | Ubiquitination | TVYSGEEKLTELLVK CEECCHHHHHHHHHH | 57.30 | 23000965 | |
155 | Acetylation | TVYSGEEKLTELLVK CEECCHHHHHHHHHH | 57.30 | 23236377 | |
167 | Ubiquitination | LVKAYGDFAWSNPLH HHHHHCCCCCCCCCC | 6.96 | 23503661 | |
183 | Ubiquitination | DIFPGLRKIEAEIVR CCCCCHHHHHHHHHH | 50.36 | 21890473 | |
228 | Ubiquitination | YRDLAFEKGIKTPEI HHHHHHHCCCCCCCC | 60.53 | 21906983 | |
231 | Ubiquitination | LAFEKGIKTPEIVAP HHHHCCCCCCCCCCC | 67.69 | 23503661 | |
240 | Phosphorylation | PEIVAPQSAHAAFNK CCCCCCHHHHHHHHH | 22.44 | - | |
247 | Ubiquitination | SAHAAFNKAASYFGM HHHHHHHHHHHHHCC | 38.59 | 23503661 | |
247 | Methylation | SAHAAFNKAASYFGM HHHHHHHHHHHHHCC | 38.59 | 115981337 | |
263 | Ubiquitination | IVRVPLTKMMEVDVR EEEEECCCHHHHHHH | 43.88 | 21890473 | |
342 | Ubiquitination | HPFDFRVKGVTSISA CCCCEEEECEEEEEC | 43.33 | 2190698 | |
345 | Ubiquitination | DFRVKGVTSISADTH CEEEECEEEEECCCC | 29.07 | 27667366 | |
353 | Ubiquitination | SISADTHKYGYAPKG EEECCCCCCEECCCC | 42.32 | 29901268 | |
353 | Other | SISADTHKYGYAPKG EEECCCCCCEECCCC | 42.32 | - | |
353 | Acetylation | SISADTHKYGYAPKG EEECCCCCCEECCCC | 42.32 | 25825284 | |
353 | N6-(pyridoxal phosphate)lysine | SISADTHKYGYAPKG EEECCCCCCEECCCC | 42.32 | - | |
354 | Phosphorylation | ISADTHKYGYAPKGS EECCCCCCEECCCCC | 14.04 | 23898821 | |
356 | Nitrated tyrosine | ADTHKYGYAPKGSSL CCCCCCEECCCCCEE | 19.35 | - | |
356 | Phosphorylation | ADTHKYGYAPKGSSL CCCCCCEECCCCCEE | 19.35 | 23898821 | |
356 | Nitration | ADTHKYGYAPKGSSL CCCCCCEECCCCCEE | 19.35 | 16777052 | |
356 | Nitration | ADTHKYGYAPKGSSL CCCCCCEECCCCCEE | 19.35 | 16777052 | |
359 | Ubiquitination | HKYGYAPKGSSLVLY CCCEECCCCCEEEEE | 64.35 | 29967540 | |
366 | Nitrated tyrosine | KGSSLVLYSDKKYRN CCCEEEEECCCCCCC | 13.82 | - | |
366 | Nitration | KGSSLVLYSDKKYRN CCCEEEEECCCCCCC | 13.82 | 16777052 | |
366 | Nitration | KGSSLVLYSDKKYRN CCCEEEEECCCCCCC | 13.82 | 16777052 | |
369 | 2-Hydroxyisobutyrylation | SLVLYSDKKYRNYQF EEEEECCCCCCCEEE | 45.85 | - | |
401 | Phosphorylation | GSRPGGISAACWAAL CCCCCHHHHHHHHHH | 17.06 | - | |
425 | Ubiquitination | EATKQIIKTARFLKS HHHHHHHHHHHHHHH | 37.45 | 27667366 | |
449 | Phosphorylation | VFGNPQLSVIALGSR EECCCCEEEEEECCC | 13.26 | - | |
455 | Phosphorylation | LSVIALGSRDFDIYR EEEEEECCCCCEEHH | 29.53 | - | |
468 | Phosphorylation | YRLSNLMTAKGWNLN HHHHHCCCCCCCCCH | 28.52 | 17192257 | |
507 | Phosphorylation | FLKDIRESVTQIMKN HHHHHHHHHHHHHHC | 22.18 | - | |
509 | Phosphorylation | KDIRESVTQIMKNPK HHHHHHHHHHHHCCC | 22.96 | - | |
542 | Phosphorylation | RNMVAELSSVFLDSL HHHHHHHHHHHHHHC | 18.89 | 20068231 | |
543 | Phosphorylation | NMVAELSSVFLDSLY HHHHHHHHHHHHHCC | 29.52 | 29496963 | |
548 | Phosphorylation | LSSVFLDSLYSTDTV HHHHHHHHCCCCCCC | 31.21 | 27174698 | |
550 | Phosphorylation | SVFLDSLYSTDTVTQ HHHHHHCCCCCCCCC | 17.30 | 27174698 | |
551 | Phosphorylation | VFLDSLYSTDTVTQG HHHHHCCCCCCCCCC | 25.71 | 26074081 | |
552 | Phosphorylation | FLDSLYSTDTVTQGS HHHHCCCCCCCCCCC | 23.33 | 18691976 | |
554 | Phosphorylation | DSLYSTDTVTQGSQM HHCCCCCCCCCCCCC | 26.07 | 20068231 | |
556 | Phosphorylation | LYSTDTVTQGSQMNG CCCCCCCCCCCCCCC | 29.34 | 20068231 | |
559 | Phosphorylation | TDTVTQGSQMNGSPK CCCCCCCCCCCCCCC | 19.21 | 25159151 | |
564 | Phosphorylation | QGSQMNGSPKPH--- CCCCCCCCCCCC--- | 25.42 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SGPL1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SGPL1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SGPL1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ATP5L_HUMAN | ATP5L | physical | 26344197 | |
TM9S4_HUMAN | TM9SF4 | physical | 26344197 | |
TRIM9_HUMAN | TRIM9 | physical | 28514442 | |
AIFM1_HUMAN | AIFM1 | physical | 28514442 | |
MO4L1_HUMAN | MORF4L1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-353, AND MASS SPECTROMETRY. | |
Nitration | |
Reference | PubMed |
"Nitroproteins from a human pituitary adenoma tissue discovered with anitrotyrosine affinity column and tandem mass spectrometry."; Zhan X., Desiderio D.M.; Anal. Biochem. 354:279-289(2006). Cited for: NITRATION [LARGE SCALE ANALYSIS] AT TYR-356 AND TYR-366, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-564, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-468, AND MASSSPECTROMETRY. |